Table 4 Multivariable analyses of various prognostic parameters in patients with HCC
From: Role of IQGAP3 in metastasis and epithelial–mesenchymal transition in human hepatocellular carcinoma
Variable | B | Wald | P | Relative risk | 95% confidence interval |
|---|---|---|---|---|---|
Age (years) | 0.363 | 2.970 | 0.085 | 1.437 | 0.951–2.170 |
Gender | 0.159 | 0.223 | 0.636 | 1.173 | 0.606–2.271 |
Clinical stage | 0.071 | 0.054 | 0.816 | 1.074 | 0.590–1.954 |
Cirrhosis | −0.288 | 1.880 | 0.170 | 0.750 | 0.497–1.132 |
T classification | 0.038 | 0.123 | 0.726 | 1.039 | 0.839–1.287 |
N classification | −0.416 | 0.674 | 0.412 | 0.660 | 0.244–1.781 |
M classification | −0.934 | 2.133 | 0.144 | 0.393 | 0.112–1.377 |
HCV | −11.647 | 0.001 | 0.970 | 0.000 | 0–3.964E + 259 |
HBsAg | −0.310 | 0.012 | 0.912 | 0.969 | 0.553–1.697 |
IQGAP3 | 0.922 | 15.835 | 0.001 | 2.513 | 1.596–3.957 |